No Data
No Data
What the Options Market Tells Us About Pfizer
Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer (NYSE:PFE) revealed 8 unusual trades.Delving into the details, we found 37% of traders were
Decoding 13 Analyst Evaluations For Intl Flavors & Fragrances
In the latest quarter, 13 analysts provided ratings for Intl Flavors & Fragrances (NYSE:IFF), showcasing a mix of bullish and bearish perspectives.In the table below, you'll find a summary of their re
Morgan Stanley Maintains Equal-Weight on Intl Flavors & Fragrances, Raises Price Target to $103
Morgan Stanley analyst Lisa De Neve maintains Intl Flavors & Fragrances (NYSE:IFF) with a Equal-Weight and raises the price target from $100 to $103.
Intl Flavors & Fragrances Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/03/2024 8.18% Morgan Stanley $100 → $103 Maintains Equal-Weight 06/07/2024 21.84% Oppenheimer → $116 In
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Wednesday, GSK plc (NYSE:GSK) and CureVac N.V. (NASDAQ:CVAC) announced they have restructured their existing collaboration into a new licensing agreement, allowing the companies to prioritize investme
COVID Infections Could Be Seeing a Summer Surge Based on CDC Data